Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03658642 · ClinicalTrials.gov registry record · NA
Clinical Decision Support to Implement ED-initiated Buprenorphine for OUD
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 5,047
- Enrollment target
NCT03658642: Completed NA study, sponsored by Yale University.
NCT03658642 is a NA study that has completed, run by Yale University. The registered enrollment target is 5,047 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (259% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03658642, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 5,047 participants
- Enrollment target
Study Summary
Emergency Departments (EDs) frequently care for individuals with Opioid Use Disorder (OUD). Buprenorphine (BUP) is an effective treatment option for patients with OUD that can safely be initiated in the ED. At present, BUP is rarely initiated as a part of routine ED care. Clinical decision support (CDS) represents a potential approach to accelerate adoption of this best practice into routine emergency care. The goal of this trial is to determine whether implementation of a user-centered clinical decision support (CDS) system can increase adoption of initiation of BUP into the routine emergency care of individuals with OUD.
Primary Outcome
The primary outcome will be Buprenorphine (BUP) initiation in the Emergency Department (ED), defined as whether or not an eligible patient is administered BUP in the ED and/or prescribed BUP upon discharge from the ED. Although this is not a patient-centered outcome, it is a pragmatic and meaningful surrogate that will serve as a lead indicator of the CDS intervention's effect on engaging more OUD patients in treatment. Medications for Opioid Use Disorder (MOUD)
Interventions
- BEHAVIORAL Clinical Decision Support (CDS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,047 participants |
| Start Date | 2019-11-15 |
| Est. Completion | 2021-09-15 |
| Phase | NA |
What the finished NCT03658642 record still lists
NCT03658642 is an interventional study that assigns participants to a tested intervention. Its 5,047 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (259% higher).
The record links to 0 conditions, and to 1 intervention - of which Clinical Decision Support (CDS) is the first listed.
NCT03658642 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03658642 about?
NCT03658642 is a clinical study titled "Clinical Decision Support to Implement ED-initiated Buprenorphine for OUD". Emergency Departments (EDs) frequently care for individuals with Opioid Use Disorder (OUD). Buprenorphine (BUP) is an effective treatment option for patients with OUD that can safely be initiated in the ED. At present, BUP is rarely initiated as a part of routine ED care. Clinical decision support (...
What is the current status of trial NCT03658642?
This trial is currently completed. It is a NA study. The enrollment target is 5,047 participants. The study started on 2019-11-15. Estimated completion is 2021-09-15.
What interventions are being tested in trial NCT03658642?
The interventions under investigation include: Clinical Decision Support (CDS) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03658642?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03658642's enrollment target sits among peer trials
5,047 25th of 2000 higher than 1,976 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07037459 · 5,056 participants · Phase 3
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- NCT06292078 · 5,076 participants · NA
Preventing School Exclusion and Opioid Misuse: Effectiveness of the Inclusive Skill-building Learning Approach (ISLA)
- NCT04743362 · 5,010 participants
A Study of Noninvasive Methods to Evaluate Skin and Mucosal Conditions
- NCT00060541 · 5,000 participants
Evaluation and Treatment of Neurosurgical Disorders
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI